Amazon recently announced that it is shuttering its Halo division, a line of wearable health and fitness devices. This marks the third time in about two years that the e-commerce giant has closed one its healthcare businesses — Amazon Care failed last year, and Haven failed in 2021.
Jeff Sherman, chief technology officer of Zephyr AI, a company that aims to transform precision medicine from diagnostics to treatment. How exactly does it plan to do that? Listen below to know more.
At MedCity INVEST we highlight the trends in investment and innovation across biopharma, diagnostics, medical devices and health tech (payer/provider and consumer/employer). This is your opportunity to connect and network in 5-star comfort. Last week to save $200.
Merck, Sanofi, and Eli Lilly joined the Series A financing of Therini Bio, a startup developing a drug that selectively targets fibrin as a way of reducing disease-driving inflammation in neurodegeneration and eye disorders such as diabetic macular edema. Therini is preparing to advance its lead program to clinical testing.
Too often today, BIPOC communities must deal with mental health obstacles without the necessary education, support, and coping strategies. Fortunately, healthcare organizations have opportunities to start addressing these challenges by building cultural competency and by strengthening community education, trust, and access.
In some ways, the Drug Enforcement Agency's (DEA) proposed rules for prescribing controlled substances via telemedicine are a sign of progress. Behavioral health could be getting some much-needed clarity, but at what cos
The Rockefeller Foundation is funding two produce prescription pilot programs at VA healthcare systems in Salt Lake City, Utah, and Houston, Texas. Eligible veterans will be able to enroll in About Fresh's Fresh Connect program, which provides $100 per month through a debit card, allowing the veterans to buy healthy foods at the grocery store.
This season, we will be focusing on artificial intelligence in healthcare. Our very first interview is with Jeff Sherman, chief technology officer of Zephyr AI, a company that aims to transform precision medicine from diagnostics to treatment. How exactly does it plan to do that? Listen to find out.
No comments:
Post a Comment